Solvay Pharma India Ltd.[Amalgamated] - Research Center
532447 DUPHARPH Group (N.A.) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Dec ' 10 | Dec ' 09 | Dec ' 08 | Dec ' 07 | Dec ' 06 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 5.05 | 5.05 | 5.05 | 5.05 | 5.05 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 160.88 | 125.04 | 104.22 | 81.75 | 77.01 |
| Loan funds | |||||
| Secured loans | - | - | - | - | 0.04 |
| Unsecured loans | - | - | - | - | - |
| Total | 165.93 | 130.09 | 109.27 | 86.80 | 82.10 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 62.43 | 64.23 | 27.83 | 8.20 | 10.24 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 26.77 | 26.69 | 25.37 | 3.79 | 3.15 |
| Net block | 35.66 | 37.54 | 2.46 | 4.41 | 7.09 |
| Capital work-in-progress | - | - | 35.15 | 0.06 | 0.10 |
| Investments | 36.67 | 15.93 | 16.66 | 39.84 | 14.02 |
| Net current assets | |||||
| Current assets, loans & advances | 148.75 | 118.25 | 102.89 | 74.45 | 86.69 |
| Less : current liabilities & provisions | 55.15 | 41.63 | 47.90 | 31.96 | 25.80 |
| Total net current assets | 93.60 | 76.62 | 54.99 | 42.49 | 60.89 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 165.93 | 130.09 | 109.27 | 86.80 | 82.10 |
| Notes: | |||||
| Book value of unquoted investments | 36.67 | 15.93 | 16.66 | 39.84 | 14.02 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 5.57 | 3.48 | 5.15 | 2.38 | 0.12 |
| Number of equity sharesoutstanding (Lacs) | 50.50 | 50.50 | 50.50 | 50.50 | 50.50 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis